JFL Life Sciences Limited (NSE:JFLLIFE)
India flag India · Delayed Price · Currency is INR
11.80
+0.55 (4.89%)
At close: Nov 6, 2026

JFL Life Sciences Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,9961,314820.42470.19442.1343.1
Revenue Growth
168.06%60.15%74.49%6.35%28.85%4.70%
Gross Profit
210.59149.2157.0769.1792.784.3
Operating Income
144.29106.472.0746.1148.757
Net Income
90.2164.0141.583328.128
Earnings Per Share
2.741.941.261.000.971.37
EPS Growth
242.45%53.97%26.00%3.57%-29.52%346.69%

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
8.1614.620.644.410.61.9
Total Debt
216.52217.29105.956.9271.8158.5
Net Cash (Debt)
-208.36-202.67-105.26-52.51-71.2-156.6
Net Cash Growth
------
Net Cash Per Share
-6.33-6.14-3.19-1.59-2.45-7.66

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-61.66-43.31-35.5784.08-90.523.3
Capital Expenditures
-32.83-33.79-3.95-61.13--17
Free Cash Flow
-94.49-77.09-39.5222.95-90.56.3
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
10.55%11.36%19.14%14.71%20.97%24.57%
Operating Margin
7.23%8.10%8.78%9.81%11.02%16.61%
Pretax Margin
6.06%6.54%7.48%8.07%8.41%11.05%
Profit Margin
4.52%4.87%5.07%7.02%6.36%8.16%
FCF Margin
-4.73%-5.87%-4.82%4.88%-20.47%1.84%

Dividends

Fiscal Year
FY 2024
Period EndingMar '24
Dividend Per Share
0.083
Dividend Per Share Growth
-
Dividend Yield
0.64%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
4.304.4113.8513.1112.92-
P/FCF Ratio
---18.86--
PS Ratio
0.200.220.700.920.82-